Pri­vate eq­ui­ty firm Per­mi­ra buys phar­ma ser­vice provider Er­gomed in £703.1M deal

Pri­vate eq­ui­ty com­pa­ny Per­mi­ra has ac­quired pub­licly-list­ed phar­ma ser­vice provider Er­gomed in a cash agree­ment worth £703.1 mil­lion ($883 mil­lion), with the deal slat­ed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER